日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

An Optimized Full-Length FLT3/CD3 Bispecific Antibody Demonstrates Potent Anti-leukemia Activity and Reversible Hematological Toxicity

优化的全长 FLT3/CD3 双特异性抗体表现出强效的抗白血病活性和可逆的血液学毒性

Yik Andy Yeung, Veena Krishnamoorthy, Danielle Dettling, Cesar Sommer, Kris Poulsen, Irene Ni, Amber Pham, Wei Chen, Sindy Liao-Chan, Kevin Lindquist, S Michael Chin, Allison Given Chunyk, Wenyue Hu, Barbra Sasu, Javier Chaparro-Riggers, Ivana Djuretic

Optimal design, anti-tumour efficacy and tolerability of anti-CXCR4 antibody drug conjugates

抗CXCR4抗体药物偶联物的最佳设计、抗肿瘤疗效和耐受性

Maria José Costa ,Jyothirmayee Kudaravalli ,Jing-Tyan Ma ,Wei-Hsien Ho ,Kathy Delaria ,Charles Holz ,Angela Stauffer ,Allison Given Chunyk ,Qing Zong ,Eileen Blasi ,Bernard Buetow ,Thomas-Toan Tran ,Kevin Lindquist ,Magdalena Dorywalska ,Arvind Rajpal ,David L Shelton ,Pavel Strop ,Shu-Hui Liu